Larson Yi

EVP & Chief Financial Officer at Turning Point Therapeutics, Inc.

Sold, on record
$3.8M
Dollars the filings state
Form 4 sales
1
Latest Feb 2, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Feb 2 2021

    Sold 30,000 shares at $126.73 ($3.8M)

    Larson Yi, EVP & Chief Financial Officer

    Sold 91.7% of holdings ($4.1M position)2,704 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Larson Yi
Source
Feb 2, 2021Turning Point Therapeutics, Inc.EVP & Chief Financial OfficerForm 4 sale30,000$3.8M91.7%UnusualSEC